Northlane Capital Partners (“NCP”) announced today that it has made an investment in SAI MedPartners (“SAI”), a leading consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries.
Northlane Capital Partners (“NCP”) announced today that it has made an investment in SAI MedPartners (“SAI”), a leading consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries.
Ready to take your business to the next level? Our team of experts are here to provide the strategic advice and tailored solutions you need to excel.